99 related articles for article (PubMed ID: 30397888)
1. Polyprenyl Phosphates Induce a High Humoral and Cellular Response to Immunization with Recombinant Proteins of the Replicative Complex of the Hepatitis C Virus.
Masalova OV; Lesnova EI; Onishchuk AA; Ivanova AM; Gerasimova EV; Ivanov AV; Narovlyansky AN; Sanin AV; Pronin AV; Kushch AA
Dokl Biochem Biophys; 2018 Sep; 482(1):261-263. PubMed ID: 30397888
[TBL] [Abstract][Full Text] [Related]
2. The adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae:
Lesnova EI; Masalova OV; Permyakova KY; Demidova NA; Valuev-Elliston VT; Ivanov AV; Kushch AA
Vopr Virusol; 2023 Sep; 68(4):315-326. PubMed ID: 38156588
[TBL] [Abstract][Full Text] [Related]
3. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
4. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
5. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein].
Masalova OV; Lesnova EI; Andreev SM; Shershakova NN; Kozlov VV; Permyakova KY; Demidova NA; Valuev-Elliston VT; Turetskiy EA; Ivanov AV; Nikolaeva TN; Khaitov MR; Pronin AV; Kushch AA
Vopr Virusol; 2023 Feb; 67(6):516-526. PubMed ID: 37264841
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
[TBL] [Abstract][Full Text] [Related]
9. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
Qiao M; Murata K; Davis AR; Jeong SH; Liang TJ
Hepatology; 2003 Jan; 37(1):52-9. PubMed ID: 12500188
[TBL] [Abstract][Full Text] [Related]
11. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
13. Development of HCV Therapeutic Vaccines Using Hp91 Peptide and Small Heat Shock Protein 20 as an Adjuvant.
Basirnejad M; Bolhassani A
Protein Pept Lett; 2018; 25(10):924-932. PubMed ID: 30255740
[TBL] [Abstract][Full Text] [Related]
14. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571
[TBL] [Abstract][Full Text] [Related]
15. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
17. The adjuvant effect of C
Liu J; Feng X; Chen Z; Yang X; Shen Z; Guo M; Deng F; Liu Y; Zhang H; Chen C
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():753-759. PubMed ID: 30678964
[TBL] [Abstract][Full Text] [Related]
18. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
[TBL] [Abstract][Full Text] [Related]
19. The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model.
Mehrlatifan S; Mirnurollahi SM; Motevalli F; Rahimi P; Soleymani S; Bolhassani A
Drug Deliv; 2016 Oct; 23(8):2852-2859. PubMed ID: 26559939
[TBL] [Abstract][Full Text] [Related]
20. N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
Tao W; Zheng HQ; Fu T; He ZJ; Hong Y
Hum Vaccin Immunother; 2017 Aug; 13(8):1818-1822. PubMed ID: 28604244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
